6 Studies That Bring Good News to the "Battle of Omicron"
Sexy Sheath Women Black Dress Sleeveless
https://bit.ly/3u9ktIl = US $9.37
Recent laboratory studies revealed the effectiveness of “Merck” capsules with the mutant Omicron from the Corona virus.
On Friday, Merck & Co. and its partner, Ridgeback Biotherapeutics, said that six laboratory studies showed that their experimental drug, molonopiravir, was effective with the rapidly spreading mutant Ommicron.
The data evaluated the efficacy of molnopiravir capsules and other antiviral treatments in tackling worrisome strains of coronavirus. The two companies said they had not yet tested molnopiravir against Omicron in human studies.
And the relevant authorities in the United States approved the use of Molnopiravir and other tablets produced by Pfizer in December, and these two treatments are considered among the important means to confront Omicron.
Pfizer said in December that lab data indicated that its drug baxlovid retained its effectiveness against Omicron.
Merck said earlier this month that its capsules have properties that allow it to counteract Omicron and any other mutated strain.
No comments:
Post a Comment
Leave your comment or question here and we will respond to it